bioSeedin

bioSeedin is a leading financial services firm dedicated to connecting novel therapeutics, emerging science, and technological assets with global partners and resources. As a subsidiary of ACROBiosystems Group, bioSeedin operates across North America, Europe, and Asia, offering unparalleled expertise in asset management, public relations, and financial advisory services for biotech and pharmaceutical companies. bioSeedin's primary address is located at 1 Broadway, Floor 14, Cambridge, MA 02142, US, with additional offices in Newark, Delaware; San Jose, California; Beijing, Hangzhou, Shanghai and Suzhou, China; Frankfurt, Germany; Basel, Switzerland; and South Croydon, England.

Leveraging its extensive network and deep industry insights, bioSeedin provides a comprehensive suite of services, including licensing, co-developmental partner sourcing, and project implementation. The company excels in advising on public relations management, Asia market entry, investment strategy, mergers and acquisitions, and capital raising, ensuring clients achieve their strategic goals and maximize their market potential. bioSeedin aims to be the premier asset transaction platform, fostering R&D efficiency, optimizing research resource utilization, and facilitating emerging market access to expedite the delivery of therapeutics and benefit patients worldwide.

With a commitment to excellence and a global perspective, bioSeedin is poised to drive innovation and growth in the biopharmaceutical industry. The company's dedication to connecting stakeholders and facilitating strategic partnerships makes it an invaluable resource for companies seeking to expand their reach and impact. We invite the management team at bioSeedin to enhance your company's visibility by creating a customized and exclusive company showcase and product listing on our platform. bioSeedin information will be completed soon with the support of the company’s management.